Navigation Links
SuperArray Bioscience Corporation Licenses RNA Interference Patent From The Carnegie Institution
Date:11/30/2007

FREDERICK, Md, Nov. 30 /PRNewswire/ -- SuperArray Bioscience Corporation announced today that it has entered into a RNA Interference (RNAi) license agreement with The Carnegie Institution. Under the agreement, SuperArray Bioscience Corporation will develop, manufacture and distribute worldwide RNA interference based gene function and mechanism of action research tools.

The agreement enables SuperArray to offer RNAi-based gene silencing products for gene function studies including gene-specific small interfering RNA (siRNA) and DNA-based RNA interference expressing short hairpin RNA (shRNA). The agreement also allows SuperArray to pass on rights to end-user customers in the research field for the performance of DNA-based RNA Interference.

RNA Interference is a key technology in life science research, particularly in gene function studies and in drug target identification. A small piece of RNA with complete sequence identity to a target gene of interest is introduced or "transfected" into an in vitro mammalian cell culture system. A normal cellular process uses the small RNA to identify and degrade the messenger RNA responsible for the expression of the same targeted gene. Suppressing the expression of the gene removes the activity of its protein product. The researcher then performs other biological experiments with the cells to determine the missing or changed activity and to attribute that activity to the gene of interest.

"We are very excited to offer RNA Interference-based gene function research tools using the technologies from The Carnegie Institution," said Dr. Paul Nisson, Senior Director of Technology Development at SuperArray Bioscience Inc. "Our combination of a multi-purpose plasmid backbone and a rigorously experimentally verified design algorithm to produce gene-specific RNA Interference for every gene in human, rat and mouse genome will help biomedical researchers identify the function of novel genes or further explore
'/>"/>

SOURCE SuperArray Bioscience Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
3. Professionals in bioscience, food-related industries turn to K-State
4. Aeon Bioscience Continues Development of Drug Eluting Stents
5. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
6. Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran
7. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
8. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
9. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
10. Anaptys Biosciences Raises Over $33 Million in Series B Financing
11. YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...unications announces a highly effective and unconv...ggling to make an economic recovery. , ...rs is the type of challenge that could send ailing... Dr. David Benton, business growth expert and auth...dash; The Rfactor Intensive . “Fear is on...
(Date:11/25/2009)...ire/--TheBartleHallConventionCenterwilltemporarily...enKansasCityhoststhelatestinaseriesofmassivefreecl...thasthepotentialtobethebiggestoneyet,becauseitwill...ysinsteadofoveraweekend,"SheriWood,executivedirect...NationalAssociationofFreeClinics(NAFC). ,, Atpr...
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofbreastMR...teofnewleadingedgeclinicalapplicationsonitsAegis(T...ogicalSocietyofNorthAmerica(RSNA)annualmeetinginCh...ationsleveragetheuniquehighqualityimagesgeneratedb...ultipleimagingmodalitiesformulti-parametricassessm...
(Date:11/25/2009)...USNewswire/--TheBlackAIDSInstituterecentlyheldBoar...for2010. ,, ThenewBoardMembersareahighlydiverse...nance,governmenthealthprograms,editorial,andbusine...ofpersonalbackgroundsincludingbothheterosexualandg...representingmultipleagegroups. ,, (Photo: http:...
(Date:11/25/2009)...ancer who were treated with cisplatin-based chemot...rological side effects and Raynaud-like phenomena,...according to a new study published online November...te . , Marianne Brydy, M.D., of the Department o...en, Norway, and colleagues conducted a cross-secti...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...ology says that it is possible to reduce high bloo... Scientists, in an attempt to study the effects of...lar responses, had found out the result from the r...lectro-puncture. Acupuncture is one of the t...
... laproscopic surgery, may require the use of a pul...ays a study published in the new issue of Archives...hat has a genetic component and often gets magnifi...ne of the most common procedures to control morbid...
... inner ear may restore partial hearing ability of ...n Nature Medicine. Scientists are of the ... regulatory gene called Atoh1 can be used to encou...cells of the inner ear are encouraged to change th...
...lic Health had found out that the intake of vitami...erosis (MS) in women. The study said that women wh...e of developing MS than the ones who did not take ...odern day treatment may slow the course of develop...
...like keratitis by wearing the latest silicone hydr...rnal// of Ophthalmology. Scientists showed th...ar or extended wear contact lenses have varied res...tudy and had used a clinical severity matrix to di...
...cer patients and people without liver cancer found...developing liver cancer compared to the general po...nt, such as demographics and major risk factors fo...cancer, may be boosting the risk even further. ...
Other Medicine News:
(Date:11/25/2009)...Newswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),...rminimallydisruptivesurgicaltreatmentsforthespine,...y,November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfe...sementfortheCompany,sproductsandwillincludecomment...ssion.Thedial-innumbersare1-877-407-4018fordomesti...
(Date:11/25/2009)...dSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareInt...ovatorandprovideroflessinvasive,miniaturizedcircul...tofadvancedheartfailure,todayannouncedthatitissche...perJaffrayHealthCareConferenceat8:00amESTonWednesd...YorkPalaceHotel,December1-2. ,, Alivewebcastoft...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--QuestDiagnosticsIncorpora...tictesting,informationandservices,announcedthatiti...careConferenceinNewYorkCity.Thepresentationissched...me. ,, Duringtheconference,thecompanywillreaffi...peratingincometoexceed18%ofrevenues,anddilutedearn...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 1Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 2Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14 2009 56735 1NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 1NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 2NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 3NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 4
...ls that multiply and migrate in the, embryo to giv... a finding, that suggests that these cells might ...n., Oct. 3 Investigators at St.,Jude Children,s R...he,origin of the mammalian lymphatic vasculature -...to various essential housekeeping functions in the...
...maceuticals, Inc. (Nasdaq: TPPH ) announced today...i-center study of TPI 287 in patients with,advance...ial exploring the,activity of TPI 287 in various t...this year in advanced hormone refractory prostate ...oved for pancreatic cancer and,effective treatment...
Other Medicine Technology:St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5
CRP FULL RANGE (0.1-160 mg/l)
Uric Acid (UA)
Apolipoprotein B (undiluted sample) Liquid
Urea (Kinetic) 3 minute read
Medicine Products: